Design Therapeutics, Inc.·4

Dec 11, 4:30 PM ET

Shah Pratik 4

4 · Design Therapeutics, Inc. · Filed Dec 11, 2025

Insider Transaction Report

Form 4
Period: 2025-12-09
Shah Pratik
DirectorPresident, CEO and Chairperson
Transactions
  • Award

    Stock option (right to buy)

    2025-12-09+525,000525,000 total
    Exercise: $2.48Common Stock (525,000 underlying)
Footnotes (1)
  • [F1]On September 1, 2023, the Reporting Person was granted an option to purchase 525,000 shares of common stock. 25% of the shares subject to the option would vest on August 25, 2024, and thereafter the balance would vest in equal monthly installments over the following 36 months, provided that, as an additional condition, no shares under the option would vest until the Issuer achieved a specific performance condition. On December 9, 2025, the Issuer's Board of Directors deemed that the performance condition had been met, resulting in vesting of the option as to 295,312 shares. The remainder of the unvested shares subject to the option shall vest monthly through August 25, 2027 subject to the continuous service of the Reporting Person through each such date.

Documents

1 file
  • 4
    form4-12112025_041203.xmlPrimary